USSPX vs. ARKG

Last updated Jun 4, 2026

USSPX (USAA 500 Index Fund) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both funds - USSPX is a Large Cap Blend Equities fund managed by Victory, while ARKG is a Health & Biotech Equities fund actively managed by ARK. Over the past 10 years, USSPX returned 15.58%/yr vs 7.22%/yr for ARKG. A 0.59 correlation means they provide meaningful diversification when combined. USSPX charges 0.24%/yr vs 0.75%/yr for ARKG.

Performance

USSPX vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in USAA 500 Index Fund (USSPX) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, USSPX achieves a 11.92% return, which is significantly lower than ARKG's 17.09% return. Over the past 10 years, USSPX has outperformed ARKG with an annualized return of 15.58%, while ARKG has yielded a comparatively lower 7.22% annualized return.

USSPX

• 1D: 0.20%
• 1M: 5.97%
• YTD: 11.92%
• 6M: 11.78%
• 1Y: 28.83%
• 3Y*: 22.87%
• 5Y*: 14.05%
• 10Y*: 15.58%

ARKG

• 1D: -0.24%
• 1M: 10.92%
• YTD: 17.09%
• 6M: 10.02%
• 1Y: 53.35%
• 3Y*: 0.67%
• 5Y*: -15.72%
• 10Y*: 7.22%

*Multi-year figures are annualized to reflect compound growth (CAGR)

USSPX vs. ARKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
USSPX USAA 500 Index Fund	11.92%	17.63%	25.04%	26.99%	-19.37%	27.45%	21.21%	31.19%	-4.66%	21.19%
ARKG ARK Genomic Revolution Multi-Sector ETF	17.09%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	180.40%	44.00%	-1.26%	46.61%

Correlation

The correlation between USSPX and ARKG is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.56
Correlation (3Y) Calculated over the trailing 3-year period	0.59
Correlation (5Y) Calculated over the trailing 5-year period	0.62
Correlation (10Y) Calculated over the trailing 10-year period	0.61
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014	0.59

The correlation between USSPX and ARKG has been stable across timeframes, ranging from 0.56 to 0.62 - a consistent structural relationship.

Return for Risk

USSPX vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USSPX

USSPX Risk / Return Rank: 72
USSPX Sharpe Ratio Rank: 73
USSPX Sortino Ratio Rank: 66
USSPX Omega Ratio Rank: 65
USSPX Calmar Ratio Rank: 73
USSPX Martin Ratio Rank: 82

ARKG

ARKG Risk / Return Rank: 35
ARKG Sharpe Ratio Rank: 35
ARKG Sortino Ratio Rank: 37
ARKG Omega Ratio Rank: 32
ARKG Calmar Ratio Rank: 38
ARKG Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USSPX vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for USAA 500 Index Fund (USSPX) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	USSPX	ARKG	Difference
Sharpe ratio: Return per unit of total volatility	2.49	1.31	+1.18
Sortino ratio: Return per unit of downside risk	3.38	1.99	+1.39
Omega ratio: Gain probability vs. loss probability	1.45	1.22	+0.23
Calmar ratio: Return relative to maximum drawdown	3.33	1.95	+1.38
Martin ratio: Return relative to average drawdown	15.45	4.67	+10.78
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

USSPX vs. ARKG - Sharpe Ratio Comparison

The current USSPX Sharpe Ratio is 2.49, which is higher than the ARKG Sharpe Ratio of 1.31. The chart below compares the historical Sharpe Ratios of USSPX and ARKG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	USSPX	ARKG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.49	1.31	+1.18
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.81	-0.35	+1.15
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.85	0.18	+0.68
Sharpe Ratio (All Time) Calculated using the full available price history	0.54	0.13	+0.41

Drawdowns

USSPX vs. ARKG - Drawdown Comparison

The maximum USSPX drawdown since its inception was -55.39%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for USSPX and ARKG.

Drawdown Indicators

	USSPX	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-55.39%	-83.59%	+28.20%
Max Drawdown (1Y) Largest decline over 1 year	-8.92%	-27.51%	+18.59%
Max Drawdown (3Y) Largest decline over 3 years	-19.64%	-51.96%	+32.32%
Max Drawdown (5Y) Largest decline over 5 years	-26.88%	-80.18%	+53.30%
Max Drawdown (10Y) Largest decline over 10 years	-33.64%	-83.59%	+49.95%
Current Drawdown Current decline from peak	0.00%	-69.65%	+69.65%
Average Drawdown Average peak-to-trough decline	-10.13%	-35.87%	+25.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.92%	11.46%	-9.54%

Volatility

USSPX vs. ARKG - Volatility Comparison

The current volatility for USAA 500 Index Fund (USSPX) is 2.82%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that USSPX experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	USSPX	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	2.82%	11.90%	-9.08%
Volatility (6M) Calculated over the trailing 6-month period	9.04%	28.77%	-19.73%
Volatility (1Y) Calculated over the trailing 1-year period	11.95%	41.12%	-29.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.49%	45.61%	-28.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.36%	41.12%	-22.76%

USSPX vs. ARKG - Expense Ratio Comparison

USSPX has a 0.24% expense ratio, which is lower than ARKG's 0.75% expense ratio.

Dividends

USSPX vs. ARKG - Dividend Comparison

USSPX's dividend yield for the trailing twelve months is around 3.71%, while ARKG has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%	0.00%	0.00%
USSPX USAA 500 Index Fund	3.71%	4.14%	3.63%	2.07%	2.81%	4.98%	3.38%	4.98%	3.03%	1.34%	2.34%	1.89%

Frequently Asked Questions

Can I hold both USSPX and ARKG in my portfolio?

USSPX and ARKG have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, USSPX or ARKG?

ARKG has higher volatility (11.90%) compared to USSPX (2.82%). In terms of maximum drawdown, USSPX dropped -55.39% vs ARKG's -83.59%.

Which has better risk-adjusted returns?

USSPX currently has the higher Sharpe Ratio (2.49 vs 1.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.